Interdisziplinärer Expertenkonsensus zu Innovationen der bildgebenden Diagnostik und radionuklidbasierten Therapien des fortgeschrittenen Prostatakarzinoms

20215 citationsReviewhybrid Open Access

Authors

Dirk Beyersdorff · University Medical Center Hamburg-Eppendorf

Kambiz Rahbar · University Hospital Münster

Markus Essler · University Hospital Bonn

Ute Ganswindt · Innsbruck Medical University

Anca-Ligia Grosu · University Medical Center Freiburg

Jürgen E. Gschwend · Klinikum rechts der Isar

Kurt Miller

Abstract

Provided by the working group are suggestions and strategies to improve the implementation of new imaging techniques such as multiparametric magnetic resonance imaging (mpMRI), PSMA-PET/CT (prostate-specific membrane antigen-positron emission tomography/computed tomography) and innovative therapeutic options (radium-223 dichloride, lutetium-177-PSMA) in the complex treatment of metastatic castration-resistant prostate cancer (mCRPC).

Topics & Keywords

Prostate Cancer Treatment and Research Prostate Cancer Diagnosis and Treatment Radiopharmaceutical Chemistry and Applications

UN Sustainable Development Goals

Industry, innovation and infrastructure

Publication Details

Published in: Der Urologe

Volume 60, Issue 12, pp. 1579-1585

DOI: 10.1007/s00120-021-01598-2

Field-Weighted Citation Impact: 0.59